Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Tofacitinib might be used to treat hair loss.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Tislelizumab can cause cutaneous lupus erythematosus.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

PPX causes much less hair loss than traditional taxanes.

Tofacitinib taken by mouth helps treat hair loss in children.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Tofacitinib treatment is used for teenagers with alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Baricitinib may effectively treat oral lichen planus.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Abrocitinib may effectively treat Lichen Planopilaris.